May 31, 2024

Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:

• Introduction (0:00)
• The Biology of Head and Neck Cancer (15:41)
• The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
• Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
• Radiation Therapy and Chemotherapy Side Effects (41:02)
• The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
• Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
• Tolerability Considerations with Xevinapant (1:06:13)
• The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
• Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
• The Tolerability of Immune Checkpoint Inhibitors (1:24:09)

NCPD information and select publications